Nasal spray could deliver drug directly to childhood brain tumors
Disease control
Not yet recruiting
This early-phase trial tests whether a nasal spray called NEO100 can safely reach brain tumors in children with aggressive brain cancers like diffuse midline glioma. About 12 children will receive increasing doses to find the safest amount and check for side effects. The goal is …
Phase: PHASE1 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 03, 2026 02:36 UTC